📰 Twist Bioscience News
Page 2 - Twist Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Twist Bioscience. Real-time updates on events, politics, business and more.
May 4, 2024
Twist Bioscience (NASDAQ:TWST – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.79) EPS for the quarter, beating analysts’ consensus estimates of ($0.84) by $0.05, Briefing.com reports. The firm had revenue of $75.30 million for the quarter, compared to analysts’ expectations of $70.70 million. Twist Bioscience had a negative return […]
May 3, 2024
Twist Bioscience develop a sensitive approach to fusion transcript detection using targeted RNA sequencing
May 3, 2024
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued growth momentum. Analysts reaffirm Outperform ratings.
May 2, 2024
Twist Bioscience develop a sensitive approach to fusion transcript detection using targeted RNA sequencing
April 25, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total value of $65,480.88. Following the sale, the chief operating officer now owns 176,206 shares […]
April 25, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) COO Patrick John Finn sold 2,174 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $30.12, for a total transaction of $65,480.88. Following the completion of the sale, the chief operating officer now directly owns […]
April 24, 2024
These synthetic gene fragments are being recognized for receiving consistently outstanding customer feedback, again
April 23, 2024
These synthetic gene fragments are being recognized for receiving consistently outstanding customer feedback, again
April 18, 2024
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report)’s stock price fell 4.4% during mid-day trading on Tuesday . The stock traded as low as $27.90 and last traded at $27.95. 98,884 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 907,806 shares. The stock had previously closed at […]
April 10, 2024
Thematic ETFs are an easy way to play a trend rather than trying to pick a winner.